Reimbursement Variance Detection
Identify unusually high, low, or inconsistent reimbursement patterns across drug records, plans, carriers, and state-level datasets.
Medicaid · Medicare · Program Integrity · Carrier Intelligence
Government intelligence for healthcare spend oversight.
Adrastia Analytics supports agencies, oversight teams, and public-sector partners with high-clarity reimbursement intelligence, targeted variance review, and executive-ready reporting for Medicaid and Medicare environments.
NDC-level review
NADAC-aligned benchmarking
Carrier variance intelligence
Audit-ready reporting
Program IntegritySupports review, prioritization, and targeted recovery strategy.
Carrier IntelligenceCompares plan behavior across states, markets, and drug categories.
Executive ClarityTurns large reimbursement files into briefings leaders can act on.
Mission
Find avoidable spend. Prioritize review. Support public accountability.
Adrastia Analytics is built for agencies, oversight units, and public-sector partners that need a clearer view of prescription-drug reimbursement variance across Medicaid and Medicare environments.
Our work focuses on actionable reporting, defensible prioritization, and structured review outputs. We provide leadership-ready findings, clean exhibits, and practical briefing materials for responsible public-sector review.
Capabilities
High-value intelligence for government healthcare spend.
Designed for Medicaid agencies, Medicare oversight teams, OIG-style review groups, state procurement leaders, and public-sector recovery partners.
NADAC-Aligned Benchmarking
Compare plan-submitted pricing behavior against recognized acquisition-cost benchmarks to support review prioritization.
Carrier & Plan Intelligence
Map pricing behavior across organizations and markets to understand where outliers are concentrated and where review may matter most.
State-by-State Reporting
Create public-sector briefing packages organized by geography, carrier, drug, NDC, variance level, and review priority.
Audit-Ready Evidence Packages
Package findings with clean tables, plain-language summaries, and traceable review fields for agency validation and escalation.
Executive Decision Support
Condense large reimbursement datasets into ranked opportunities, issue summaries, and leadership-ready briefing materials.
Deliverables
Clear outputs for serious review.
Adrastia deliverables are built to help public officials understand the scale, concentration, and priority of reimbursement findings without unnecessary technical noise.
- Executive summaries for agency leadership
- Carrier and plan variance tables
- NDC-level issue prioritization
- State-focused briefing packets
- Review-ready exhibits and trace fields
- Follow-up scoping for deeper validation
Macro ViewState, carrier, and plan-level variance summaries.
Target ViewDrug, NDC, and outlier-specific review packages.
Action ViewPrioritized issue lists for program-integrity follow-up.
Governance & Engagement
Built for responsible public-sector review.
Adrastia Analytics supports scoped, auditable engagements for agencies, oversight teams, and partners seeking clearer reimbursement intelligence.
Data disciplineEngagements are scoped around authorized, lawful, and appropriate data sources.
Review supportFindings are decision support and should be validated through agency, payer, or legal review workflows.
Clear documentationBriefings are structured for traceability, review, and leadership communication.
Procurement readyBriefings can support agency discussions, procurement review, pilot scoping, and formal engagement planning.
Request Briefing
Government, carrier, and oversight inquiries.
Use the request form for agency briefings, pilot discussions, procurement questions, or state-specific reimbursement intelligence inquiries.
Mailing Address
Adrastia Analytics
6545 Market Ave N Ste 100
Canton, OH 44721
Important Notice
Adrastia Analytics provides analytical decision support and briefing materials. Findings are not legal advice, medical advice, or final agency determinations. Any recovery, enforcement, procurement, or policy action should be validated by the appropriate government, legal, compliance, or payer-review authority.